Peptide record

TPDB06973

Antibacterial Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06973
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 13-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
WKKILSKIKKLLK
Physicochemical Analysis
C80H144N20O15
ARNDCEQGHMFPTYV
K
1626.15
11.21
6
0
6
+6
1.92
-0.362
150.00
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
5500
338.22
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
3
L
6
K
0
M
0
F
0
P
1
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 3 K: 6 M: 0 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
13
C80H144N20O15
1626.15
11.21
+6
1.92
-0.362
Evidence Records 11 records
Evidence 1 Activity

Activity

MIC
Antibacterial
3.13 µM

Target

Staphylococcus aureus

Source & Reference

NA

Other

active against Gram+ S. aureus (MIC 3.13 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 5.00 uM), S. epiderm
Evidence 2 Activity

Activity

MIC
Antibacterial
2.50 µM

Target

Enterococcus faecalis

Source & Reference

NA

Other

active against Gram+ S. aureus (MIC 3.13 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 5.00 uM), S. epidermidis (MIC 3.13 uM), Gram- E
Evidence 3 Activity

Activity

MIC
Antibacterial
1.56 µM

Target

E. faecium

Source & Reference

NA

Other

active against Gram+ S. aureus (MIC 3.13 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 5.00 uM), S. epidermidis (MIC 3.13 uM), Gram- E. coli (MIC 3.13 uM), P. a
Evidence 4 Activity

Activity

MIC
Antibacterial
5.00 µM

Target

B. cereus

Source & Reference

NA

Other

ainst Gram+ S. aureus (MIC 3.13 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 5.00 uM), S. epidermidis (MIC 3.13 uM), Gram- E. coli (MIC 3.13 uM), P. aeruginosa including resis
Evidence 5 Activity

Activity

MIC
Antibacterial
3.13 µM

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

C 3.13 uM), E. faecalis (MIC 2.50 uM), E. faecium (MIC 1.56 uM), B. cereus (MIC 5.00 uM), S. epidermidis (MIC 3.13 uM), Gram- E. coli (MIC 3.13 uM), P. aeruginosa including resistant MRPA0108 persisters (MIC
Evidence 6 Activity

Activity

MIC
Antibacterial
3.13 µM

Target

Escherichia coli

Source & Reference

NA

Other

), E. faecium (MIC 1.56 uM), B. cereus (MIC 5.00 uM), S. epidermidis (MIC 3.13 uM), Gram- E. coli (MIC 3.13 uM), P. aeruginosa including resistant MRPA0108 persisters (MIC 3.13-6.25 uM), K. pneumoniae
Evidence 7 Activity

Activity

MIC
Antibacterial
3.13-6.25 µM

Target

Pseudomonas aeruginosa including resistant MRPA0108 persisters

Source & Reference

NA

Other

uM), B. cereus (MIC 5.00 uM), S. epidermidis (MIC 3.13 uM), Gram- E. coli (MIC 3.13 uM), P. aeruginosa including resistant MRPA0108 persisters (MIC 3.13-6.25 uM), K. pneumoniae (MIC 25 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 6.25 uM).
Evidence 8 Activity

Activity

MIC
Antibacterial
25 µM

Target

Klebsiella pneumoniae

Source & Reference

NA

Other

(MIC 3.13 uM), P. aeruginosa including resistant MRPA0108 persisters (MIC 3.13-6.25 uM), K. pneumoniae (MIC 25 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 6.25 uM).
Evidence 9 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

Enterobacter cloacae

Source & Reference

NA

Other

sa including resistant MRPA0108 persisters (MIC 3.13-6.25 uM), K. pneumoniae (MIC 25 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 6.25 uM).
Evidence 10 Activity

Activity

MIC
Antibacterial
6.25 µM

Target

P. mirabilis

Source & Reference

NA

Other

8 persisters (MIC 3.13-6.25 uM), K. pneumoniae (MIC 25 uM), E. cloacae (MIC 12.5 uM), and P. mirabilis (MIC 6.25 uM).
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
>500 µM
Hemolytic Cytotoxic
50% Hemolysis | >500 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action. | J Appl Microbiol | 2013